Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
Shaherin Basith, Balachandran Manavalan, Tae Hyeon Yoo, et al.
Archives of Pharmacal Research (2012) Vol. 35, Iss. 8, pp. 1297-1316
Closed Access | Times Cited: 197

Showing 1-25 of 197 citing articles:

Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay Kumar
International Immunopharmacology (2018) Vol. 59, pp. 391-412
Open Access | Times Cited: 571
Mechanisms and pathways of innate immune activation and regulation in health and cancer
Jun Cui, Yongjun Chen, Helen Y. Wang, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3270-3285
Open Access | Times Cited: 274
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Zuzanna Urban‐Wójciuk, Mohd M. Khan, Benjamin L. Oyler, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 258
AIPpred: Sequence-Based Prediction of Anti-inflammatory Peptides Using Random Forest
Balachandran Manavalan, Tae Hwan Shin, Myeong O. Kim, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 194
Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
Marion Dajon, Kristina Iribarren, Isabelle Cremer
Immunobiology (2016) Vol. 222, Iss. 1, pp. 89-100
Closed Access | Times Cited: 187
Periodontal disease and cancer: Epidemiologic studies and possible mechanisms
Ngozi N. Nwizu, Jean Wactawski‐Wende, Robert J. Genco
Periodontology 2000 (2020) Vol. 83, Iss. 1, pp. 213-233
Open Access | Times Cited: 174
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 61
Toll‐like receptors in health and disease
Kunyu Wang, Hanyao Huang, Zhan Qi, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 22
Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination
Zhenzhen Zhan, Xuefeng Xie, Hao Cao, et al.
Autophagy (2013) Vol. 10, Iss. 2, pp. 257-268
Open Access | Times Cited: 178
Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment—Poor Prognosis or New Therapeutic Opportunity
Lisa A. Ridnour, Robert Y.S. Cheng, Christopher Switzer, et al.
Clinical Cancer Research (2012) Vol. 19, Iss. 6, pp. 1340-1346
Open Access | Times Cited: 139
Negative regulatory approaches to the attenuation of Toll-like receptor signaling
Muhammad Ayaz Anwar, Shaherin Basith, Sangdun Choi
Experimental & Molecular Medicine (2013) Vol. 45, Iss. 2, pp. e11-e11
Open Access | Times Cited: 134
Combinatorial prospects of nano-targeted chemoimmunotherapy
Candido G. Da Silva, Félix Rueda, Clemens W.G.M. Löwik, et al.
Biomaterials (2016) Vol. 83, pp. 308-320
Closed Access | Times Cited: 119
Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort
Ngozi N. Nwizu, James R. Marshall, Kirsten B. Moysich, et al.
Cancer Epidemiology Biomarkers & Prevention (2017) Vol. 26, Iss. 8, pp. 1255-1265
Open Access | Times Cited: 110
TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition
Jin Koo Kim, Younghun Jung, Jingcheng Wang, et al.
Neoplasia (2013) Vol. 15, Iss. 9, pp. 1064-1074
Open Access | Times Cited: 107
Targeting Toll-Like Receptors for Cancer Therapy
Marc J. Braunstein, John Kucharczyk, Sylvia Adams
Targeted Oncology (2018) Vol. 13, Iss. 5, pp. 583-598
Closed Access | Times Cited: 98
Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
Dhanusha Yesudhas, Vijayakumar Gosu, Muhammad Ayaz Anwar, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 95
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
Stefano Federico, Luca Pozzetti, Alessandro Papa, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13466-13513
Closed Access | Times Cited: 93
Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis
Smitha Pillai, Jonathan V. Nguyen, Joseph Johnson, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 91
Harnessing cancer immunotherapy during the unexploited immediate perioperative period
Pini Matzner, Elad Sandbank, Elad Neeman, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 5, pp. 313-326
Closed Access | Times Cited: 83
Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
Saghar Pahlavanneshan, Ali Sayadmanesh, Hamidreza Ebrahimiyan, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 74
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 68
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
Samik Chakraborty, Juan Ye, Herui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 34
The emerging role of oral microbiota in oral cancer initiation, progression and stemness
Partha Jyoti Saikia, Lekhika Pathak, Shirsajit Mitra, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Extracellular vesicles from Aggregatibacter actinomycetemcomitans exhibit potential antitumorigenic effects in oral cancer: a comparative in vitro study
Marjut Metsäniitty, Shrabon Hasnat, Carina Öhman, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 6
Open Access | Times Cited: 8
Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-κB
Ji-Woong Kwon, Hyuk‐Kwon Kwon, Hyeon‐Jun Shin, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top